MRI Investigations in Attention Deficit Hyperactivity Disorder (ADHD) and High Potential (HP) Children for a Better Therapeutic Approach
HP
1 other identifier
interventional
74
1 country
1
Brief Summary
Impulsivity and/or hyperactivity in children has become one of the main clinical symptom for consultation, among the most frequent, in general or pediatric medicine. Among the different clinical forms of instability, ADHD appears to be an especially disabling condition for the development of the child, both in psychomotor, cognitive, emotional and relational aspects. Further, a significant link between ADHD children and some children with High Potential (HP) is observed. HP children show overall ahead cognitive developments compared to children with the same age. In these children, as well as in children with ADHD, an attention vulnerability, psychomotor deficits are noted, as well as emotional and relational deficits that significantly contrasted with some of their cognitive skills. Regarding the HP, the hypothesis is that children with significantly heterogeneous results (Complex) to the Wechsler IV scales are affected by this shift, and hence, by the difficulty of a differential diagnosis with ADHD, unlike those whose intelligence quotient (IQ) results that are more homogeneous (Laminar). The goal of this work was to study a population of 80 children aged from 8 to 12 years (20 subjects per group) to evaluate the functional and structural brain development by:
- Functional magnetic resonance imaging (fMRI) acquisitions with cognitive stimulations, involving attention, working memory and semantic processing, and emotional stimulations,
- fMRI acquisitions at rest (without activation),
- diffusion tensor magnetic resonance imaging (DTI) acquisitions,
- 3D anatomic acquisitions. Identification of developmental differences in certain cortical brain areas (eg, prefrontal vs parietal), white matter fiber bundles or functional networks preferentially used by one or other of these groups, will help to better understand this disease, and to improve the differential diagnosis in order to implement a more appropriate and personalized management of the patients via new therapeutic strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 9, 2016
CompletedFirst Posted
Study publicly available on registry
July 6, 2016
CompletedJuly 6, 2016
June 1, 2016
1.8 years
June 9, 2016
June 30, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Cortical gray matter (GM) volumes
using the software VBM (Voxel Based Morphometry)
Day 1
Microstructural connectivity of white matter (WM) fiber bundles
measured by diffusion tensor imaging. Diffusion metrics maps are compared using the software TBSS (Track Based Spatial Statistics),
Day 1
Functional MRI activity during cognitive tests
using the software SPM (Statistical Parametric Mapping)
Day 1
Functional connectivity in resting-state fMRI
using the CONN toolbox (functional connectivity toolbox) of SPM (Statistical Parametric Mapping)
Day 1
Subcortical gray matter (GM) volumes
using the software VBM (Voxel Based Morphometry)
Day 1
Functional MRI activity during emotional tests
using the software SPM (Statistical Parametric Mapping)
Day 1
Functional connectivity in resting-state fMRI
using the graph-theory methods
Day 1
Study Arms (4)
Laminar HP
EXPERIMENTALStructural and functional MRI markers
Complex HP
EXPERIMENTALStructural and functional MRI markers
ADHD
EXPERIMENTALStructural and functional MRI markers
Control
OTHERStructural and functional MRI markers
Interventions
MRI and neuropsychological assessment planned for the study for patient and volunteers
Eligibility Criteria
You may qualify if:
- Right-hand 4 groups :
- Laminar HP : IQ \> 130 and difference between Verbal Comprehension Index (VCI) and Perceptual Reasoning Index (PRI) \< 9
- Complex HP : IQ \> 130 and difference between VCI and PRI \>15
- ADHD : 90 \< IQ \<110
- Controls : 90 \< IQ \<110
You may not qualify if:
- Subjects with any psychiatric disorders except ADHD,
- Subjects with known learning deficits (dyslexia, dysphasia…), attention deficits except for ADHD group
- Subjects with claustrophobia or magnetic devices
- Children with out both parental agreements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de psychiatrie infantile, Hôpital Pierre Wertheimer, 59 Boulevard Pinel
Bron, 69500, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Olivier REVOL, MD
HCL
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2016
First Posted
July 6, 2016
Study Start
May 1, 2013
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
July 6, 2016
Record last verified: 2016-06